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Abstract
The objectives of this overview are to describe the past and potential
contributions of birth cohorts to understanding chronic disease aetiol-
ogy; advance a justification for the maintenance of birth cohorts from
low- and middle-income countries (LMIC); provide an audit of birth
cohorts from LMIC; and, finally, offer possible future directions for
this sphere of research. While the contribution of birth cohorts from
affluent societies to understanding disease aetiology has been consid-
erable, we describe several reasons to anticipate why the results from
such studies might not be directly applied to LMIC. More than any
other developing country, Brazil has a tradition of establishing, main-
taining and exploiting birth cohort studies. The clear need for a
broader geographical representation may be precipitated by a greater
collaboration worldwide in the sharing of ideas, fieldwork experience,
and cross-country cohort data comparisons in order to carry out the
best science in the most efficient manner. This requires the involve-
ment of a central overseeing body - such as the World Health Organ-
ization - that has the respect of all countries and the capacity to develop
strategic plans for ‘global’ life-course epidemiology while addressing
such issues as data-sharing. For rapid progress to be made, however,
there must be minimal bureaucratic entanglements.
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Introduction
Rates of non-communicable diseases such
as cardiovascular disease (CVD) and many
malignancies are declining in most indus-
trialised countries; however, they remain the
leading causes of death (1). Whilst inad-
equate infrastructure in some countries makes
routine collection of health data difficult,
there is growing evidence that non-commu-
nicable diseases are also becoming increas-
ingly prevalent in low- and middle-income
countries (LMIC), including Brazil (2). The
predictions are that such disorders will be-
come the predominant cause of mortality by
2020, representing 70% of all deaths (3). As
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has been highlighted (4), what is often ig-
nored in considering such statistics is the
impact of less lethal, but nonetheless debili-
tating diseases such as psychiatric illness: by
the same year it is estimated that clinical
depression will become the number one cause
of disability-adjusted life years in develop-
ing societies (3). The added presence of
communicable diseases - HIV/AIDS, ma-
laria, tuberculosis, acute respiratory infec-
tions, diarrheal disease and other vaccine-
preventable illnesses - and, in women, seri-
ous obstetric complications, has raised well-
documented concerns of a dual burden of
disease amongst the world’s poor.
A large number of studies using observa-
tional designs (chiefly cohort and case-con-
trol), representing a research tradition be-
ginning in the 1940s America (5), have been
conducted in middle- and older-aged per-
sons in high-income countries. These have
offered crucial insights into understanding
the aetiology of non-communicable diseases.
Notable examples include work pioneered
by Doll et al. (6,7) that identified the link
between cigarette smoking and lung cancer,
heart disease and other adverse health out-
comes, and, more recently, studies estab-
lishing the causal associations of both high
blood pressure (8) and dyslipidemia (9) with
CVD. These findings have been instrumen-
tal in the development of interventions
(lifestyle and pharmacological) that have
resulted in population-level declines in these
risk factors, treatment of those at highest
risk, and ultimately decreases in CVD mor-
bidity and mortality rates.
Despite these successes, there are de-
bates about the extent to which these now
established, major adult risk factors, when
measured solely in mid-life, fully explain
the variation in important chronic diseases,
such as CVD (10,11). Some investigators
have argued that these risk factors explain
most of the geographical and secular varia-
tions in non-communicable diseases, such
as CVD, and that there is no need to search
further (12). However, this focus on adult
risk factors, which is consistent with a de-
generative model of non-communicable dis-
ease epidemiology, pays scant attention to
processes that lead up to the peak or optimal
phenotypic states that are usually a feature
of adolescence or early adulthood, and that
are increasingly recognised as relevant to
non-communicable disease risk in adulthood.
In humans, these optimal phenotypic states
include peak bone mass (usually attained
post-puberty), peak respiratory function (usu-
ally attained in the early 20s), and peak
arterial function (usually attained by the age
of 15-20 years). This more recent approach
to understanding disease processes thus
recognises the development of anatomical
and physiological systems, in addition to
how rapidly one degenerates from this opti-
mum, as having important relevance to the
occurrence of non-communicable diseases.
A life-course approach to risk factor
identification
Support for the importance of develop-
mental processes in the aetiology of adult
non-communicable diseases, particularly
CVD, can be found in studies employing
diverse research designs. First, pathological
investigations have revealed evidence of ath-
erosclerosis - the precursor to coronary heart
disease - in males as young as 15 years of age
(13). Second, levels of established mid-life
risk factors for selected cancers and CVD
(physical inactivity, raised blood pressure,
obesity, etc.) seem to ‘track’ between child-
hood and adulthood, such that children at
high risk tend to become adults at high risk
(14). Third, for adult-targeted lifestyle modi-
fication designed to reduce coronary heart
disease rates, results are typically modest
(15), suggesting that earlier intervention may
have some benefit. Finally, in a small but
growing literature, several of the classic
markers of disease risk identified in adult
populations - smoking, raised blood pres-
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Figure 1. Number of publications referring to birth cohort studies in the last 20 years (1985-
2006). Based on a search of the PubMed database (http://www.ncbi.nlm.nih.gov/sites/
entrez?db=PubMed) for any article containing the terms “birth cohort study” or “birth-cohort
study”; no language restrictions.
sure, obesity - also seem to be predictive of
later CVD and cancer risk when measured in
younger populations who are followed into
middle- and older-age (16). These findings
have been derived from cohort studies, some-
times birth cohort studies, which are the
focus of the present issue of the Brazilian
Journal of Medical and Biological Research
which features a series of reports from the
Ribeirão Preto and São Luís cohorts.
A birth cohort study can be defined as the
collection of data at follow-up survey,
through passive (that is, routinely collected
information; e.g., hospital admissions, death
registration or educational records) and/or
active (e.g., medical examination) means, of
a group of individuals born around the same
time (this may stretch to a few days, or, in
some studies, years) over a given period
(often decades). In Latin, cohors refers to a
group of warriors within a Roman legion
(17). Alternative terms for cohort study in-
clude longitudinal or panel study. These in-
vestigations are also sometimes referred to
as pregnancy cohorts or family cohorts,
recognising that for some (e.g., Avon Longi-
tudinal Study of Parents and Children (18)
and Mater-University of Queensland Study
of Pregnancy (19)) recruitment was of moth-
ers in early pregnancy - sometimes by iden-
tifying those who were seeking to become
pregnant. Using this approach, information
on parents and children is gathered during
the follow-up period. Such studies differ
from many birth cohorts (e.g., UK 1946,
1958) that recruited infants at birth in that
they are better able to evaluate the role of
(intrauterine) exposures such as maternal
diet, smoking and alcohol consumption on
both the future health of the index child (so-
called trans-generational or intergenerational
influences) and the mother. That cohort stud-
ies may utilise retrospective and/or prospec-
tive data collection is essentially irrelevant -
though overemphasised by some - as the
logic of any association is always forward.
Prompted by this body of work pointing
to the importance of both developmental and
degenerative processes in the aetiology of
adult disease, a “life-course” paradigm has
been proposed which offers a framework for
identifying the long-term effect on adult dis-
ease of social, physiological, behavioural,
and psychological processes operating dur-
ing gestation, childhood, adolescence, adult-
hood, and between generations (20). This
approach therefore emphasises a combina-
tion of measures of developmental and de-
generative processes from across the life
span and, ideally, between generations. The
last two decades have witnessed a marked
rise in research output in this area as evi-
denced by the increasing number of publica-
tions over the last 20 years citing the use of
birth cohort studies on which much of the
understanding of life-course influences on
health is based (Figure 1).
Contribution of birth cohorts from
high-income countries
To date, much of what is known about the
developmental origins of adult disease has
been gleaned from cohort studies based on
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high-income countries (for examples, see Table
1). This is largely the product of affluence
which manifests itself in several ways. First,
these societies have the medical research fund-
ing to facilitate the initiation and maintenance
of cohorts. Second, births typically occur in
hospitals, rather than the home, and home
visits by a medical practitioner during infancy
(often with routine collection of standard data
on growth and development) are common-
place, thus facilitating systematic documenta-
tion of early life characteristics. Third, surveil-
lance of cohort members is less problematic
than in non-industrialised countries owing to a
lower prevalence of internal (rural to urban)
migration and the capacity to trace persons
passively through national databases. This is
particularly evident in the Scandinavian coun-
tries where unique person identification num-
bers have expedited the process (see for ex-
ample, reports based on Swedish (21-23) and
Danish (24,25) population-based studies).
These cohorts, together with basic sci-
ence studies, have contributed to an increased
understanding of the developmental origins
of non-communicable diseases. There have
been replicated associations of measures of
growth in utero and post-natally with CVD
and type 2 diabetes (26,27); childhood and
life-course socio-economic adversity with
CVD, diabetes, selected cancers, psychiatric
illnesses and trauma in adulthood (28), and
exposures around the time of pubertal devel-
opment with hormone-related cancers (29).
More recently, low mental ability (IQ) in
childhood has been shown to be related to an
elevated risk of subsequent all-cause mortal-
ity, CVD and some psychiatric illnesses (24,
30). However, the mechanisms underlying
some of these associations are unclear and
sometimes difficult to interpret (31,32). The
relationship between measures of intrauter-
ine growth and postnatal growth with adult
disease is a pertinent example. Even if it is
accepted that these associations are not fully
explained by statistical artefact or confound-
Table 1. Birth cohort studies from economically developed and developing countries.
Name key citation Location Birth years(s) Cohort size at induction*
High-income countries
British Cohort Studies (63-67) UK 1946, 1958, 1970, ~2000 Range: 5362-20,000
Avon Longitudinal Study of Parents and Children (18,68) England 1991/2 13,971
Aberdeen Children of the 1950s Study (34,69) Scotland 1950-6 12,150
Northern Finland Birth Cohort (48) Finland 1966 12,058
Danish National Birth Cohort (70) Denmark 1997-2003 Births to 100,000 women**
National Collaborative Perinatal Project (71) US (selected sites active) 1959-66 633
Dunedin Multidisciplinary Health and Development Study (72) New Zealand 1972/73 1037
Mater-University of Queensland Study of Pregnancy (19) Australia 1981/84 7223
Low- and middle-income countries
South Dehi Cohort (43) India 1969-72 8181
Human Capital Study (73) Guatemala 1969-77 1301
1982 Pelotas Birth Cohort Study (41,74) Brazil 1982 5914
1993 Pelotas Birth Cohort Study (74) Brazil 1993 5249
2004 Pelotas Birth Cohort Study (74) Brazil 2004 2403
1978/79 Ribeirão Preto Birth Cohort Study (75,76) Brazil 1978/79 6827
1994 Ribeirão Preto Birth Cohort Study (76) Brazil 1994 2846
1997/98 São Luís Birth Cohort Study (76) Brazil 1997/98 2443
Cebu cohort (77,78) Philippines 1983/84 2080
Birth to Twenty Cohort (60-62) South Africa 1990 3273
Only cohorts with over 1000 study participants at induction and for which investigators continue to be research active were included in this table.
The cited cohorts from high-income countries is illustrative of those available but not exhaustive, while the cited cohorts from low- and middle-
income countries is intended to be fully comprehensive. *Cohort size occasionally varies across publications. **Projected recruitment.
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ing, it is difficult to envisage a biological
process by which growth per se during the
developmental period has a direct impact on
later disease outcomes. A more plausible
explanation is that exposures, including ge-
netic, environmental and epigenetic, that in-
fluence growth during development also in-
crease adult disease risk. Understanding the
nature of these exposures is key to prevent-
ing disease and improving health.
Whilst the contribution made by birth
cohorts in high-income countries to clarify-
ing the developmental origins of adult dis-
ease is marked, and notwithstanding the need
for further research in this area, it is notable
that, even with substantial resources and a
supportive infrastructure, maintaining birth/
pregnancy cohorts is problematic. Some of
the most important findings from such co-
horts are only likely to emerge seven or
more decades after they begin. This is be-
cause studies that can really contribute to
understanding how risk factors that influ-
ence developmental processes combine with
those affecting degenerative processes to
impact upon disease risk require cohorts that
have collected repeat, detailed information
from the parental generation, through gesta-
tion, childhood, adolescence and early adult-
hood to the point at which non-communi-
cable diseases are common. Over this time,
loss to follow-up, even in high-income coun-
tries, is likely to be considerable. For ex-
ample, in a 53-year follow-up of the 5362
infants in the 1946 UK birth cohort only
2977 cohort members (55%) provided infor-
mation (33); this is broadly in keeping with
the response in other birth cohort studies
(34). Birth cohort studies require funding
bodies and researchers who are willing to
not only commit to an investigation for some
decades, but also to accept delayed gratifica-
tion that realistically extends into the next
generation of scientists. They also require
resources to develop field methods for
maximising participant uptake and for the
development of analytical methods for de-
termining the extent to which attrition might
bias findings, a perennial problem in cohort
studies.
Why should funding bodies support
existing and future birth cohort
studies in LMIC?
Given some of the described difficulties of
establishing and maintaining birth cohorts,
together with the likelihood that several risk
factors may well be equally important in both
industrialised societies and LMIC, one could
argue that limited research funds should be
directed towards studies that evaluate popula-
tion-specific interventions aimed at reduction
of risk factors for important non-communi-
cable disease in LMIC (e.g., smoking preven-
tion programs, interventions for improving
antenatal care, re-housing studies). While this
approach has its obvious merits, we believe
that there are several important reasons for
supporting birth cohorts in LMIC.
First, there are fundamental differences
in the composition of important exposures
across countries. For example, in industria-
lised societies, most physical activity in chil-
dren and adults is accumulated in leisure
where it is vigorous and time-limited. By
contrast, in LMIC, energy expenditure is
largely occupational in nature or produced
whilst undertaking essential activities of daily
living (including transportation) where it is
typically of longer duration but of lower
intensity. Similarly, while tobacco consump-
tion in western populations mainly com-
prises inhalation from cigarettes, in South
Asia over one-third of tobacco intake is
smokeless (35). The consumption of tradi-
tional forms such as betel quid, tobacco with
lime, and tobacco tooth powder is increas-
ing. Further, when tobacco smoke is in-
haled, ‘bidis’ are more common than ciga-
rettes in selected countries such as India.
Although smaller than cigarettes, bidis po-
tentially deliver a higher dose of cancer-
causing agents (36). In a further example,
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infants who are not breast-fed in high-in-
come countries will typically receive for-
mula replacement, whereas the principal sub-
stitute in LMIC is often cow’s milk. Of
relevance to the developmental origins of
disease, there is some evidence that body
composition for a given birth size differs
between English and Indian infants, with
evidence that the so-called ‘fat-thin insulin-
resistant’ phenotype common in south Asian
adults (37-39) may be present at birth (40).
In these various instances, comparison of
the exposed and unexposed with respect to a
given health endpoint may give rise to dif-
ferent findings in samples drawn from dif-
ferent countries (41). These differences might
provide important etiological insights of ben-
efit to individuals from all populations.
Second, the confounding structure of a
given variable may differ in LMIC. Taking
the example of breast feeding again, while
this practice is more common in affluent
groups from high-income countries, the re-
verse is the case in developing societies.
Given that, in keeping with other behav-
iours, breast feeding is a highly confounded
variable (42), this is a crucial issue in consid-
ering its relation to health outcomes. The
occurrence of consistent findings for a given
association across high-income and LMIC,
despite differential confounding structures,
would minimise concerns that confounding
is an important alternative explanation.
Third, while the relation of foetal and post-
natal growth with adult disease has, with some
exceptions (43), been examined in most detail
in cohorts drawn from affluent societies - in
particular the Hertfordshire (UK) (44) and
Helsinki (Finland) (45) historical cohorts
(Table 1) - the findings may have most rel-
evance for LMIC where the higher prevalence
of low birth weight, malnutrition and stunting
result in greater population attributable risk.
However, as discussed, the possible differ-
ence in body composition at a given birth
weight, and the uncertainty about the biologi-
cal pathways that link low birth weight and
stunted early postnatal growth to later disease
outcomes, emphasises the importance of first
establishing whether growth parameters dur-
ing developmental periods relate to adult non-
communicable disease outcomes in LMIC in
the same way that they do in high-income
countries.
Fourth, there are some exposures that are
relatively unique in LMIC and that might
have important influences on developmen-
tal and degenerative processes leading to ill-
health. For example, cancer-causing occu-
pational exposures, such as benzene (46),
are more common in non-industrialised so-
cieties where conditions of occupational hy-
giene will probably be less favourable than
in high-income countries (47). The same
may be true of wider environmental pollu-
tants, such as pesticides (48). Such expo-
sures might have lasting influences across
generations via an intrauterine effect where
women of reproductive age are exposed.
Developing a robust evidence base of the
health effects of such exposures is likely to
be important in supporting policy aimed at
maintaining economic growth that is not at
the expense of population health.
Fifth, socio-economic inequalities in
health outcomes, such as coronary heart dis-
ease, appear to differ by epoch in western
societies (49). Similarly, they are also likely
to vary by country at a single point in time. A
recent cross-country comparison of socio-
economic variation in insulin resistance in
European children (50) serves as a reminder
of this. In a more affluent country (Den-
mark), higher socio-economic position, as
indexed by family income and education,
was associated with lower (more favourable)
insulin levels, while in countries undergoing
marked social, cultural, and economic tran-
sition (Portugal and, particularly, Estonia)
the association was positive (50). The au-
thors speculated that, in the countries under-
going economic upheaval, life style changes
attributable to globalisation and urbanisation
- including a movement from a diet rich in
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complex carbohydrate and fibre to one in
which sugars and fats predominate - may be
occurring. That such changes impact most
rapidly upon affluent individuals in coun-
tries experiencing such transitions might ex-
plain the results.
Finally, the replication of established risk
factor-disease relationships in LMIC may
have important, positive political ramifica-
tions. For example, it has been speculated
that the absence of specific data for LMIC
has led to the importance of cigarette smok-
ing as a major cause of death being seriously
underestimated by the medical profession,
the media and government in those countries
(4). It has been claimed, for example, that
smoking, a well-established risk factor for
CVD in developed nations (see earlier), may
be less detrimental to CVD outcomes in east
Asian countries where cholesterol levels are
low (51). This myth may at least partially
explain the very high smoking rates amongst
men in particular in these countries (51). It is
hoped that recent analyses of large cohorts
drawn from, for instance, China (52) and
Korea (53), that clearly counter this stand-
point, together with worrying predictions of
future deaths (2), will bring about a change
in political will. Thus, even in the absence of
biological plausibly for a different expo-
sure-disease relation, it may be important to
replicate in LMIC what most epidemiolo-
gists would consider an established associa-
tion. This also has much relevance to birth
cohort studies: smoking is often initiated in
adolescence or early adulthood, and a life-
course approach using birth cohort data
should be useful in exploring the country- or
population-specific early life predictors of
this behaviour (i.e., the determinants of the
disease determinants).
Existing birth cohorts in LMIC
In Table 1 we describe a series of birth
cohort studies from LMIC that have already
contributed towards the understanding of
chronic disease aetiology, or have the poten-
tial to do so. For the purposes of comparison,
we also list some birth cohort studies from
high-income countries. Our criteria for in-
cluding studies were that they should have
recruited at least 1000 participants and that,
to our knowledge, they remain research ac-
tive (i.e., still publishing and/or collecting
follow-up data on participants). The list of
cohorts from LMIC is - we hope - exhaus-
tive, while several cohorts from high-in-
come nations could not be included owing to
page constraints (thus, these examples are
illustrative rather than exhaustive). Unsur-
prisingly, for reasons already stated, in com-
parison to cohorts from high-income socie-
ties, those from LMIC are fewer in number,
generally smaller in size, and less mature;
however, in general, they offer similarly
detailed and valuable data.
It is perhaps inevitable that, given their
characteristics, other LMIC birth cohorts are
compared with the three Pelotas (Brazil)
studies (established in 1982, 1993, 2004)
from which a series of publications have
resulted (54,55) (for a more comprehensive
listing, see a recent profile of the study (41)).
These cohorts have probably contributed
more to the knowledge base in non-indus-
trialised countries than any other from a
similar society. Important factors in the con-
tinued successful follow-up of the Pelotas
study participants have been the moderate
size of the city which makes data collection
manageable (while maintaining a reason-
able level of statistical power); rates of in-
and out-migration that are below the na-
tional average, and, perhaps crucially, fewer
apparent concerns of the inhabitants over
personal safety, so common elsewhere is
Brazil, resulting in refusal to participate be-
ing rare (41). The relative affluence of the
city of Pelotas is comparable with that of
Ribeirão Preto (cohorts established in 1978/
79 and 1994). Importantly, in 1997/98, us-
ing the same methodology, some of the ori-
ginal Ribeirão Preto cohort investigators es-
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tablished the São Luís cohort based on the
socio-economically disadvantaged north of
Brazil.
Another important feature of Table 1 is
that it highlights the regions of the world
with few or no birth cohorts. Unrepresented
are: east Asia, north Africa, the Middle East,
and the former Soviet Union, a country where
social upheaval and major problems with
substance abuse in adults (56-59) are likely
to impact upon the development of future
generations. To our knowledge, there is also
only one birth cohort in south Asia (43), a
region where there are likely to be marked
differences in exposures and developmental
processes across different countries. Simi-
larly, there is only one birth cohort in sub-
Saharan Africa (60-62).
Future directions
We have, we hope, provided some perti-
nent reasons for supporting existing and new
birth cohorts in LMIC. The clear need for a
broader geographical representation may be
precipitated by a greater collaboration world-
wide in the sharing of ideas, fieldwork expe-
rience, cross-country cohort comparisons,
and data, in order to carry out the best sci-
ence in the most efficient manner. This re-
quires the involvement of a central oversee-
ing body - such as the World Health Organ-
ization (WHO) - that has the respect of all
countries and the capacity to develop strate-
gic plans for ‘global’ life-course epidemiol-
ogy while addressing such issues as data-
sharing. For rapid progress to be made, how-
ever, there must be minimal bureaucratic
entanglements. An agency such as the WHO
should also be mindful of the worrying po-
tential of, and anecdotal evidence for, re-
search ‘neo-colonialisation’. That is, the prac-
tice by some investigators of ‘parachuting
in’ to collect data in LMIC in the absence of
full collaboration with existing researchers.
Research resources, in their broadest sense,
have to be about building local research
capacity in LMIC.
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